Next Generation Kinase Inhibitors Summit
Evvnt Promotion / evvnt
Archivio
29.03.2022 - 31.03.2022 Boston Park Plaza, 50 Park Plaza, 02116 Boston, Massachusetts, USA
Time: 13:00 to 16:45
Temi della conferenza
Celebrating 20 years of FDA approval and high efficacy profiles, kinase inhibitors have changed the face of oncology treatment. However, increasing resistance and safety issues limit the success of existing kinase inhibitor classes.
Celebrating 20 years of FDA approval and high efficacy profiles, kinase inhibitors have changed the face of oncology treatment. However, increasing resistance and safety issues limit the success of existing kinase inhibitor classes.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/944626-0?pid=4832
Speakers: Leslie Cousens, Senior Director, Search and Evaluation, Respiratory and Immunology, AstraZeneca, Markus Queisser, Scientific Director, GlaxoSmithKline, and more.
Brochure: https://go.evvnt.com/944626-0?pid=4832
Speakers: Leslie Cousens, Senior Director, Search and Evaluation, Respiratory and Immunology, AstraZeneca, Markus Queisser, Scientific Director, GlaxoSmithKline, and more.
Informazioni ed Iscrizioni:
https://go.evvnt.com/944626-1?pid=4832
Mr. Hanson Wade
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
